Ahmet Imrali
- Oncology
- Cancer Research
- Biomedical Engineering
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Co-authors
- Xueying MaoJonathan ShamashYong‐Jie LuMing-Hsin YangDaniel M. BerneyJohn HinesP. CathcartChristopher Heeschen
- Topics
- Pancreatic and Hepatic Oncology Research (5 papers)Cancer Genomics and Diagnostics (3 papers)Pancreatitis Pathology and Treatment (2 papers)
- Partner nations
- United KingdomSwitzerlandItaly
In The Last Decade
Ahmet Imrali
7 papers receiving 285 citations
Peers
Comparison fields: 5 of 50
- Oncology 216
- Cancer Research 147
- Biomedical Engineering 90
- Molecular Biology 78
- Pulmonary and Respiratory Medicine 41
Countries citing papers authored by Ahmet Imrali
This map shows the geographic impact of Ahmet Imrali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Imrali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Imrali more than expected).
Fields of papers citing papers by Ahmet Imrali
This network shows the impact of papers produced by Ahmet Imrali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Imrali. The network helps show where Ahmet Imrali may publish in the future.
Co-authorship network of co-authors of Ahmet Imrali
This figure shows the co-authorship network connecting the top 25 collaborators of Ahmet Imrali. A scholar is included among the top collaborators of Ahmet Imrali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmet Imrali. Ahmet Imrali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 20 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatin. | 27 |
| 8 | 180 | |
| 9 | 53 |
About Ahmet Imrali
Ahmet Imrali is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 9 papers that have together received 288 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (5 papers), Cancer Genomics and Diagnostics (3 papers) and Pancreatitis Pathology and Treatment (2 papers). The work is most often cited by research in Cancer Research (147 citations), Oncology (216 citations) and Biomedical Engineering (90 citations). Ahmet Imrali has collaborated with scholars based in United Kingdom, Switzerland and Italy. Frequent co-authors include Xueying Mao, Jonathan Shamash, Yong‐Jie Lu, Ming-Hsin Yang, Daniel M. Berney, John Hines, P. Cathcart, Christopher Heeschen, Lei Xu and Marc Yeste‐Velasco. Their work appears in journals such as PLoS ONE, Scientific Reports and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.